Navigation Links
Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin

Most people know pectin as a common household gelling agent in making jams and jellies, but its uses are vast. It has anticancer properties, for instance, and may have a role in important biological functions including plant growth and development and defense against disease.

Despite the importance of pectin as a major component in the primary walls of plants, scientists have known relatively little about how this family of complex polysaccharides is made. Especially perplexing has been how the synthesis of the three different classes of pectic polysaccharides is coordinated to produce the pectin matrix in cell walls.

Now, in what has been described as a "crucial breakthrough in pectin biosynthesis," a team of researchers at the University of Georgia has discovered a gene that encodes one of the proteins responsible for pectin synthesis. This is a powerful new molecular tool that could help researchers understand--and potentially manipulate--pectins.

The result, which arose from the use of biochemistry and bioinformatics to discover gene sequences, could be genetically altered pectins that might dramatically improve plant species' ability to fight disease and new pectins that could be specifically targeted to fight cancers in humans. (It has also been demonstrated that pectin lowers serum cholesterol levels.) While not the breakthrough that will allow immediate manipulation of total pectin biosynthesis, it is, one of the researchers involved said, "the first word of the Rosetta Stone that will show us the blueprint for pectin biosynthesis."

The project, led by Debra Mohnen of the UGA department of biochemistry and molecular biology and the Complex Carbohydrate Research Center, was just published in the Proceedings of the National Academy of Sciences (PNAS). Other authors of the paper include Jason Sterling, Melani Atmodjo, Sarah Inwood, V.S. Kumar Kolli, Heather Quigley and Michael Hahn.

"Numerous studies show that pectins c
'"/>

Source:University of Georgia


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. Discovery Promises Simpler Therapy for Sickle Cell Disease
6. Discovery may lead to better Candidiasis drug
7. Protein Discovery Could Unlock The Secret To Better TB Treatment
8. Discovery clarifies role of peptide in biological clock
9. Eliminate Data Analysis Bottlenecks in Drug Discovery
10. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
11. Discovery could be key to bioterrorism defense
Post Your Comments:
(Date:8/26/2015)... 2015 The report "Multi-Factor Authentication (MFA) ... Application (Travel & Immigration, Government, Banking, Defense, Commercial Security, ... 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is expected ... a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ages ...
(Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
(Date:8/24/2015)... , August 24, 2015 The consulting ... ,s largest biometrics manufacturer DERMALOG and its customized solutions and ... African Biometrics Company of the Year Award". DERMALOG is particularly ... .   -Cross reference: Picture is available ... - On Thursday evening, in South ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3
... Cold Spring Harbor, N.Y. Cancer cells grow fast. That,s ... crashed through all the cell-cycle checkpoints and are continuously growing ... they need to speed up their metabolism. CSHL ... to target the cancer cell metabolic process and in the ...
... reduce hot flashes and associated symptoms among postmenopausal ... at Baylor University,s Mind-Body Medicine Research Laboratory. , Hypnotic ... 80 percent, and the findings also showed participants experienced ... and depression. , The mind-body therapy study of 187 ...
... Liverpool have found that, like humans, obese dogs can ... issues that occur in the body at the same ... number of health problems, such as increased blood glucose ... to increase the risk of other diseases, such as ...
Cached Biology News:Team uses antisense technology that exploits gene splicing mechanism to kill cancer cells 2Team uses antisense technology that exploits gene splicing mechanism to kill cancer cells 3Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows 2Obese dogs at risk of health condition experienced by humans 2
(Date:8/27/2015)... Poway, CA (PRWEB) , ... August 27, 2015 ... ... a unique opportunity for venture capital funds, investment firms and animal health companies ... the Forum have raised $160 million. Several have also received licensing agreements or ...
(Date:8/27/2015)... ... , ... Capital Edge Consulting , a nationwide consulting firm that specializes ... ranking as one of the top 5000 companies listed on the 2015 Inc. ... , “It is truly an honor to be recognized as one of America’s fastest ...
(Date:8/27/2015)... Mich. , Aug. 27, 2015  Neogen Corporation ... acquired the stock of United Kingdom ... of microbiological culture media and diagnostic systems. ... grown into a leading provider of microbial testing and ... clinical testing markets. The company currently sells into more ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Neogen acquires U.K.-based Lab M Holdings 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
... 17, 2010 ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s ... one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) ...
... DIEGO, Aug. 17 Imagenetix, Inc. (OTC Bulletin Board: ... 30, 2010. Net sales decreased 36% for the first quarter of ... of last year.   Net loss for the first quarter was ... or $.04 per share for the same period of the prior ...
... announced today that it has initiated a phase 2 ... the treatment of PHN. XEN402 has ... and recently concluded a 21-day cumulative dose safety tolerability ... was well tolerated and achieved good drug concentrations in ...
Cached Biology Technology:Shire plc - Statement re ProAmatine 2Shire plc - Statement re ProAmatine 3Shire plc - Statement re ProAmatine 4Shire plc - Statement re ProAmatine 5Shire plc - Statement re ProAmatine 6Imagenetix, Inc. Reports First Quarter 2011 Results 2Imagenetix, Inc. Reports First Quarter 2011 Results 3Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402. 2
... monoclonal [E12] to MAP1 Light Chain MAP1A ... physical interactions between microtubules and components of the ... heavy chain subunit and multiple light chain subunits. ... of the light chain subunits and can associate ...
Image Acquisition and documentation system for fluorescent and non-fluorescent gels, membranes, blots, film, plates and assays...
PC based system for advanced chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
... features a 4.1 mega pixel digital color ... TLC color images., The cabinet features ... longwave UV tubes positioned on two sides ... fluorescence studies , Interior overhead white ...
Biology Products: